Vimarsana
Biggest News Aggregation in the World

Page 4 - That Matter News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from That Matter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In That Matter Today - Breaking & Trending Today

Kura Oncology's Menin Inhibitor Ziftomenib Selected for The Leukemia & Lymphoma Society's Pediatric Acute Leukemia (PedAL) Master Clinical Trial - Vimarsana News

Kura Oncology's Menin Inhibitor Ziftomenib Selected for The Leukemia & Lymphoma Society's Pediatric Acute Leukemia (PedAL) Master Clinical Trial

SAN DIEGO, Dec. 08, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, and The Leukemia & Lymphoma Society (LLS), the largest private funder of blood cancer research, today announced a clinical collaboration to evaluate Kura’s menin inhibitor, ziftomenib, in combination with chemotherapy in pediatric patients with relapsed/refractory KMT2A-rearranged, NUP98-

Source: yahoo.com
Exiger partners with Muir AI to empower corporations to achieve net zero with supply chain transparency, automated emissions calculations - Vimarsana News

Exiger partners with Muir AI to empower corporations to achieve net zero with supply chain transparency, automated emissions calculations

/PRNewswire/ -- Exiger, the SaaS company revolutionizing the way corporations, government agencies and banks manage supply chains, announced today a new...

The Real Reason Churches Have a Young Adult Void - Vimarsana News

The Real Reason Churches Have a Young Adult Void

As a preacher’s kid, you would think I would be prepared for this. My mom sat in church with me her whole pregnancy. I cooed along to hymns as a toddler.

Enterome Selected to The Leukemia & Lymphoma Society's Therapy Acceleration Program - Vimarsana News

Enterome Selected to The Leukemia & Lymphoma Society's Therapy Acceleration Program

LLS TAP is a strategic funding initiative to accelerate innovative blood cancer therapeutics Strategic equity investment of €3 million to support clinical advancement of EO2463 in Non-Hodgkin's Lymphoma PARIS, Oct.

Jameson Rodgers Announced As Alabama Vs. LSU Pregame Performer - Vimarsana News

Jameson Rodgers Announced As Alabama Vs. LSU Pregame Performer

Part of the Champions Lane experience has always been great live music along with multiple vendors with free giveaways and more.